Curaleaf Holdings, Inc. CURA CURLF issued an update Friday on three acquisitions: Cura Partners, Inc., Alternative Therapies Group and GR Companies Inc.
All the demands for the closing of the proposed acquisition of Cura Partners, aka Select, have been met, except for a license transfer in Oregon, Curaleaf said. Both companies are collaborating with state regulators to obtain approval and expect to close the deal no later than Feb. 1.
Benzinga's Cannabis Capital Conference returns to Miami Feb. 24-25 with North America's largest B2B cannabis gathering, bringing together capital, cannabis executives, thought leaders and more!
For the Grassroots acquisition, Curaleaf said both parties have submitted certifications of compliance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The cannabis company expects the transaction to close in the spring.
Alternative Therapies Group has applied for a change of control with the Massachusetts Cannabis Control Commission regarding the transaction with Curalef. Both Curalef and ATG are working with regulators to obtain approvals, Curaleaf said.
Curaleaf shares were trading 1.83% higher at $7.40 at the time of publication Friday.
Related Links:
Curaleaf Finalizes Acquisition Of Acres Cannabis Assets In Nevada
The Week In Cannabis: Federal Spending Bill, Vaping Bans And More Corporate Carnage
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.